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A Murine Model of Nijmegen Breakage Syndrome
neo in the Nbs1B targeted locus, deleting the BRCTBret R. Williams,1,2 Olga K. Mirzoeva,1
William F. Morgan,3 Junyu Lin,1 domain [2] (Figure 1A).
The Nbs1B allele produced an 80 kDa Nbs1 proteinWesley Dunnick,4 and John H.J. Petrini1,2,5
1Laboratory of Genetics species, Nbs1p80, which coimmunoprecipitates with
Mre11 (Figure 1B). The mRNA encoding Nbs1p80 origi-University of Wisconsin Medical School
2 Program in Cellular and Molecular Biology nated in the multiple cloning site flanking the neo marker
and contained 108 bp of intronic sequences (Figure 1C)University of Wisconsin
Madison, Wisconsin 53706 spliced to exon 6. Nbs1p80 immunoprecipitates were re-
active with antiserum recongnizing the intron-encoded3 The Radiation Oncology Research Laboratory
University of Maryland School of Medicine amino acids but not with N-terminal-specific Nbs1 anti-
serum (Figures 1B and 1D). Hence, like NBS1p70, Nbs1p80Baltimore, Maryland 21201
4 Department of Microbiology and Immunology lacks the FHA and BRCT domains encoded in exons 1
through 5 and is capable of interaction with Mre11 [2,University of Michigan Medical School
Ann Arbor, Michigan 48109-0620 11, 12]. The protein Nbs1p80 is thus identical to NBS1p70
in all but the N-terminal 66 amino acids (Figure 1E).
Summary Nbs1B/B Phenotypic Outcomes Recapitulate NBS
In contrast to null Nbs1 mutants [13], homozygous
Nijmegen breakage syndrome (NBS) is a rare autoso- Nbs1B/B cells and mice were viable. Cells established
mal recessive disorder characterized by microceph- from Nbs1B/B mice were examined to determine
aly, immunodeficiency, and predisposition to hema- whether the Nbs1B allele recapitulated the cellular phe-
topoietic malignancy [1]. The clinical and cellular notypes of NBS. SV40 transformed Nbs1B/B murine em-
phenotypes of NBS substantially overlap those of bryonic fibroblasts (MEFs), ND7, and 54-4 exhibited pro-
ataxia-telangiectasia (A-T). NBS is caused by mutation nounced sensitivity to IR (Figure 2A) and the interstrand
of the NBS1 gene, which encodes a member of the crosslinking agent mitomycin C (data not shown). DNA
Mre11 complex [2, 3], a trimeric protein complex also synthesis rates were significantly higher in irradiated
containing Mre11 and Rad50 [4]. Several lines of evi- Nbs1B/B MEFs than wild-type control MEFs 60 min after
dence indicate that the ataxia-telangiectasia mutated IR treatment (10 Gy p  0.0003, 20 Gy p  7  105,
(ATM) kinase and the Mre11 complex functionally in- Poisson) (Figure 2B), indicating that the intra S phase
teract [5]. Both NBS and A-T cells exhibit ionizing radi- checkpoint is defective in Nbs1B/B cells. As in NBS cells
ation (IR) sensitivity and defects in the intra S phase [3, 14], these phenotypic outcomes were associated with
checkpoint, resulting in radioresistant DNA synthesis failure to form IR-induced Mre11 and Nbs1 foci and mislo-
(RDS)—the failure to suppress DNA replication origin calization of the Mre11 complex in unirradiated cells (Fig-
firing after IR exposure [6]. NBS1 is phosphorylated ure 2C). The yield of chromosome aberrations following
by ATM in response to IR, and this event is required IR treatment was significantly higher in Nbs1B/B than
for activation of the intra S phase checkpoint (the RDS wild-type primary MEFs, exhibiting increases in both
checkpoint) [7–10]. We derived a murine model of NBS, deletion and exchange type aberrations (Figure 2D).
the Nbs1B/B mouse. Nbs1B/B cells are phenotypically Conflicting data regarding the influence of Nbs1 on
identical to those established from NBS patients. The p53 and its associated DNA damage-dependent check-
Nbs1B allele was synthetically lethal with ATM defi- points have been reported [15–19]. We examined
ciency. We propose that the ATM-Mre11 complex DNA changes in the p53 transcriptional target p21 following
damage response pathway is essential and that ATM IR treatment of primary MEFs. p21 induction was maxi-
or the Mre11 complex serves as a nexus to additional mal by 2 hr post IR in Nbs1B/B MEFs as well as wild-
components of the pathway. type MEFs (Figure 3A, 2 hr). These data support the
interpretation that inappropriate regulation of p53 is not
relevant to the pathology observed in NBS patientsResults and Discussion
[3, 19].
ATM also regulates the initiation of mitosis in clasto-Derivation of Nbs1B/B Mice
gen-treated cells, although data from human lymph-The 657del5 allele found in 95% of NBS patients en-
oblastoid cells regarding the role of Nbs1 in the G2/Mcodes two NBS1 protein species, a 26 kDa moiety that
checkpoint are conflicting [20, 21]. The G2/M checkpointincludes amino acids 1 to 218, and a 70 kDa species,
was analyzed in primary Nbs1B/B MEFs by measuringNBS1p70, which contains the NBS1 C terminus and
the abundance of phosphorylated histone H3, whichthereby interacts with Mre11 [1, 11]. To model NBS in
marks cells in mitosis, 60 min after IR treatment. Thethe mouse, a hypomorphic Nbs1 mutant mouse was
mitotic index of wild-type MEF cultures was reduced byderived in which NBS1 exons 4 and 5 are replaced by
15-fold (from 0.6% to 0.04%) upon IR treatment,
whereas the change in two independent Nbs1B/B pri-
mary MEF cultures was 1.7-fold, changing from 0.7%5 Correspondence: jpetrini@facstaff.wisc.edu
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Figure 1. Creation of Nbs1B Targeting Vec-
tor and Characterization of Nbs1p80
(A) Structure of Nbs1 locus and targeting vec-
tor p95N as well as the product of the tar-
geted homologous recombination event and
removal of the PGK-neo cassette by the ex-
pression of cre recombinase are shown.
Transcriptional orientation of neo is opposite
to that of Nbs1. Targeted clones were identi-
fied using a 3 external probe (BK), which de-
tects the change of a 14 kb wild-type BamHI
fragment into a novel 8 kb BamHI fragment.
In the cre-mediated excision, the 8 kb BamHI
fragment is reduced to 6 kb. The primers indi-
cated by arrows enable PCR identification of
the wild-type (s3  a7) and Nbs1B (s3  N)
as well as Nbs1Blox (s3  FlxA). Inset shows
representative Southern blot identification of
a targeted clone. BamHI digest from wild-
type (wt) and one targeted clone (B) de-
tected with BK probe are indicated. Restric-
tion sites noted: NcoI, NI; BamHI, HI; PvuII,
PII; EcoRI, RI. Introns in thin black. Exons
denoted by black boxes. Filled triangles, loxP
sites; TK, HSVtk cassette; P, PGK promoter.
(B) Immunoprecipitation from Nbs1/B ES
cell extracts was carried out with antisera to
Nbs1 (93), Mre11(59), intron 5 peptide se-
quences (36), or corresponding preimmune
and then subjected to Western blot analysis
Nbs1 (93) antiserum.
(C) The Nbs1p80 mRNA contains sequence
from the multiple cloning site (hatched line)
present in the targeting vector flanking the
PGK-neo cassette followed by 108 nucleo-
tides of intron 5 (open box) which are spliced
to exon 6 to produce Nbs1p80 mRNA. The re-
mainder of intron 5 is indicated by black box.
The presumptive translation initiation site,
present in multiple cloning site sequence, is
underlined. Splice donor (gt) and acceptor
(ag) sites present in intron 5 are boxed. Dashed line represents the splicing event. PGK indicates the location of the PGK promoter. Black
triangle indicates the loxP site.
(D) Immunoprecipitation from Nbs1/B ES cell extracts was carried out with Nbs1 antiserum (93) and blotted with Nbs1 (93), N-terminal-
specific Nbs1 (74), or its preimmune antiserum (PI). Nbs1p80 does not contain sequences in exons 1 through 5.
(E) Nbs1p80 is similar to the protein produced from the 657del5 NBS1 allele. Nbs1p80 is identical to endogenous Nbs1p95 beginning with exon 6
(boxed). NBS1p70 exhibits identity with Nbs1p95 in the middle of exon 6, downstream of the 657del5 mutation [11]. Peptides used to derive
intron 5-specific antiserum (36) are shown.
to 0.4% and 0.6% to 0.4% (p  2.76  1021, 2) (Figure exhibited ovarian dysgenesis, delayed or aberrant de-
velopment of secondary sexual characteristics are not3B). These data indicate that Nbs1 (and, by extension,
commonly observed features of NBS patients [1]. Con-the Mre11 complex) influence both the RDS and G2/M
sistent with this aspect of the NBS clinical picture,checkpoints in murine cells.
Nbs1B/B males and females were fertile, and histologi-
cal analyses reavealed no abnormalities in ovaries or
Phenotypic Features of Nbs1B/B Mice testes (data not shown).
Although the phenotypic features of Nbs1B/B MEFs re- Nbs1B/B mice were not markedly prone to malig-
capitulated those observed in NBS cells, certain aspects nancy. Tumor incidence in an aged population of 36
of the organismal phenotypes of Nbs1B/B mice were Nbs1B/B mice was not significantly higher than in het-
less severe than those of NBS patients. NBS patients erozygous and wild-type control populations (Figure
exhibit immune system defects, most commonly mani- 4A). This number of mice was sufficient to establish a
fest as IgG or IgA deficiency (49/55 patients). Immuno- 2-fold increase in tumor incidence with 95% confidence;
globulin isotype profiles of Nbs1B/B mice (aged 3–6.8 the data do not preclude a more subtle effect. Given
month) were indistinguishable from normal controls, and the DNA damage response defects in Nbs1B/B MEFs,
flow cytometric analyses indicated that splenic B and we reasoned that the Nbs1B mutation would affect the
thymic T cell populations in Nbs1B/B mice varied by metabolism of intrinsic DNA damage and enhance the
less than 25% from those in wild-type controls (data not tumor predisposition of p53-deficient mice [22]. p53/
shown). and Nbs1B/ p53/ exibited a similar tumor latency,
indicating that Nbs1B/B was recessive. However, tu-Though five of the 55 patients in the NBS registry
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Figure 2. Nbs1B/B Fibroblasts Recapitulate the Cellular Phenotypes of NBS
(A) Nbs1B/B cells are radiosensitive. IR sensitivity was determined by colony formation assay. Two wild-type, ND4 (closed diamonds) and
54-5 (closed squares), and two Nbs1B/B, ND7 (open triangles) and 54-4 (open circles), are plotted for each dose. Data shown are the result
of a representative experiment done in triplicate for each genotype at doses indicated. Colony number is normalized to untreated plates to
account for plating efficiency. Error bars indicate standard deviation.
(B) Nbs1B/B display radioresistant DNA synthesis. DNA synthesis rates in wild-type (ND4 and 54-5, open diamonds) and Nbs1B/B (ND7 and
54-4, open squares) graphed together by genotype. [14C]thymidine-labeled cells are treated with ionizing radiation, and levels of DNA synthesis
are determined 1 hr postirradiation by incorporation of [3H]thymidine. Ratios of [3H] to [14C] are determined and normalized to the untreated
samples. This plot shows a representative plot of two separate experiments, and each symbol represents an independent culture.
(C) Nbs1B/B cells are defective in the formation of ionizing radiation induced foci (IRIF). Primary wild-type (WT) and Nbs1B/B cells were
stained for Mre11 (Mre11 IF) and Nbs1 (Nbs1 IF) after mock treatment or 8 hr post IR (IR). Note the increase in cytoplasmic staining and lack
of IRIF formation as in NBS fibroblasts.
(D) Nbs1B/B cells display increased chromosomal aberrations after treatment with IR. Exponentially growing primary MEF cultures were
treated with increasing X-ray doses, and metaphase spreads were prepared for analysis of aberrations. Aberrations shown are representative
of those quantitated in the table. Exchange and reciprocal fragments arise from assymetric recombination between two chromosomes. The




mors arose in Nbs1B/B p53/ mice significantly earlier
than in p53/ mice (p  0.004, Poisson) (Figure 4B).
These observations implied that the Nbs1B mutation
was associated with the accumulation of potentially on-
cogenic genetic alterations and that lack of cancer pre-
disposition in Nbs1B/B mice was attributable to sup-
pression by p53.
Synthetic Lethality of Nbs1B and Atm Mutations
Atm/ mice recapitulate several aspects of A-T, includ-
ing defects in the RDS [23] and G2/M checkpoints (C.F.
Bender and J.H.J.P., unpublished data), defects also
observed in Nbs1B/B mice. In human cells, Nbs1 and
ATM interact in both RDS and G2/M checkpoint func-
tions. Therefore, we hypothesized that Atm deficiency
would be epistatic to the Nbs1B mutation. Nbs1B/B
mice were crossed with Atm (Atm/) mice. Whereas
Nbs1B/B mice were obtained at normal Mendelian fre-
quencies, Nbs1B/B Atm/ mice were not obtained from
either Nbs1B/ Atm/ or Nbs1B/B Atm/ intercrosses
(p  7.09  1023, Poisson) (Figure 4C). The synthetic
lethality of Nbs1B with Atm/ was manifest early in
embryogenesis, as no double mutant embryos were de-
tected at embryonic day 10 (p  0.006, Poisson) (Fig-
ure 4C).
Figure 3. Cell Cycle Checkpoint Activation in Nbs1B/B Fibroblasts A parsimonious interpretation of Nbs1B/B Atm/ syn-
(A) Nbs1B/B cells have a normal p21 response. Extracts of wild- thetic lethality is that the effects of each mutation are
type (WT) and Nbs1B/B primary MEF cultures were prepared at the additive. Inefficient metabolism of chromosomal lesions
indicated times after IR treatment. p21 levels were assessed by combined with the attenuation of checkpoint responses
Western blotting. Equivalent loading, determined by Bradford assay,
may be inconsistent with viability of the developing em-were verified by quantitative comparison to a nonspecific band as well
bryo. Whereas the decreased latency tumor latency inas to -actin (data not shown). Ratios of p21 to the nonspecific band
Nbs1B/B p53/ mice supports this interpretation, theas determined by Storm scanning are shown beneath each lane.
(B) Nbs1B/B cells exhibit a G2/M checkpoint defect. Exponentially lack of gross karyotypic instability in Nbs1B/B p53/
growing wild-type (WT) and Nbs1B/B primary MEF cultures were thymic lymphomas and MEFs (data not shown) would
treated with 10 Gy IR and harvested at 1 hr posttreatment. Cells appear to undermine it. However, rate of chromosome
were stained with a histone-H3 phosphospecific antiserum to iden-
breakage and metabolism in those cell types may not betify cells in mitosis and were scored by FACS. Graph shown is
comparable to that in rapidly dividing embryonic cells.from a representative experiment; each treatment was performed
Nbs1p70 phosphorylation is not impaired in NBS cells,in triplicate, and at least 10,000 events per sample were counted.
Mitotic index is the percentage of mitotic cells in the irradiated suggesting that physical interaction between ATM and
culture. Error bars indicate standard deviation. Mre11 complex is not abrogated in NBS cells or
Nbs1B/B mice [11]. Hence, an alternative interpretation
Figure 4. Survival and Genetic Interactions
of Nbs1B/B Mice
(A) Survival of Nbs1B/B mice. Survival of wild-
type mice (closed diamonds) and Nbs1B/B
mice (open squares) was determined. Per-
cent survival is plotted as a function of age.
(B) Survival of Nbs1/p53 mice. Twelve p53/
(open triangles), sixteen Nbs1/B p53/ (closed
diamonds), and ten Nbs1B/B p53/ (closed cir-
cles) were monitored for signs of morbidity.
Tumor latency is significantly shorter in
Nbs1B/B p53/ (p  0.004, Poisson), al-
though tumor spectrum is not different than
that of p53/ alone [22]. Out of ten Nbs1B/B
p53/ animals monitored, six lymphomas
and two teratomas were observed. Percent
survival is plotted as a function of age.
(C) Embryonic lethality of Nbs1B/B Atm/
mice. Animals were crossed to assess the
viability of Nbs1B/B Atm/ animals. For
weaning, the genotype of offspring present
21days after birth was determined (p  7.09 X 1023, Poisson). Early embryonic lethality was determined by sacrificing females with the
subsequent genotyping of observed embryos 10 days post coitus (dpc) (p  0.006, Poisson).
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